Literature DB >> 27810391

Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer.

Thomas W Rice1, Hemant Ishwaran2, Mark K Ferguson3, Eugene H Blackstone4, Peter Goldstraw5.   

Abstract

This primer for eighth edition staging of esophageal and esophagogastric epithelial cancers presents separate classifications for the clinical (cTNM), pathologic (pTNM), and postneoadjuvant pathologic (ypTNM) stage groups, which are no longer shared. For pTNM, pT1 has been subcategorized as pT1a and pT1b for the subgrouping pStage I adenocarcinoma and squamous cell carcinoma. A new, simplified esophagus-specific regional lymph node map has been introduced. Undifferentiated histologic grade (G4) has been eliminated; additional analysis is required to expose histopathologic cell type. Location has been removed as a category for pT2N0M0 squamous cell cancer. The definition of the esophagogastric junction has been revised. ypTNM stage groups are identical for both histopathologic cell types, unlike those for cTNM and pTNM.
Copyright © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AJCC/UICC eighth edition staging; Esophageal cancer; Esophagogastric cancer; Staging

Mesh：

Year:  2016        PMID： 27810391      PMCID： PMC5591443          DOI： 10.1016/j.jtho.2016.10.016

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


  7 in total

1.  Worldwide Esophageal Cancer Collaboration: clinical staging data.

Authors:  T W Rice; C Apperson-Hansen; L M DiPaola; M E Semple; T E M R Lerut; M B Orringer; L-Q Chen; W L Hofstetter; B M Smithers; V W Rusch; B P L Wijnhoven; K N Chen; A R Davies; X B D'Journo; K A Kesler; J D Luketich; M K Ferguson; J V Räsänen; R van Hillegersberg; W Fang; L Durand; W H Allum; I Cecconello; R J Cerfolio; M Pera; S M Griffin; R Burger; J-F Liu; M S Allen; S Law; T J Watson; G E Darling; W J Scott; A Duranceau; C E Denlinger; P H Schipper; H Ishwaran; E H Blackstone
Journal:  Dis Esophagus       Date:  2016-10       Impact factor: 3.429

2.  Worldwide Esophageal Cancer Collaboration: pathologic staging data.

Authors:  T W Rice; L-Q Chen; W L Hofstetter; B M Smithers; V W Rusch; B P L Wijnhoven; K L Chen; A R Davies; X B D'Journo; K A Kesler; J D Luketich; M K Ferguson; J V Räsänen; R van Hillegersberg; W Fang; L Durand; I Cecconello; W H Allum; R J Cerfolio; M Pera; S M Griffin; R Burger; J-F Liu; M S Allen; S Law; T J Watson; G E Darling; W J Scott; A Duranceau; C E Denlinger; P H Schipper; T E M R Lerut; M B Orringer; H Ishwaran; C Apperson-Hansen; L M DiPaola; M E Semple; E H Blackstone
Journal:  Dis Esophagus       Date:  2016-10       Impact factor: 3.429

3.  Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.

Authors:  T W Rice; T E M R Lerut; M B Orringer; L-Q Chen; W L Hofstetter; B M Smithers; V W Rusch; J van Lanschot; K N Chen; A R Davies; X B D'Journo; K A Kesler; J D Luketich; M K Ferguson; J V Räsänen; R van Hillegersberg; W Fang; L Durand; W H Allum; I Cecconello; R J Cerfolio; M Pera; S M Griffin; R Burger; J-F Liu; M S Allen; S Law; T J Watson; G E Darling; W J Scott; A Duranceau; C E Denlinger; P H Schipper; H Ishwaran; C Apperson-Hansen; L M DiPaola; M E Semple; E H Blackstone
Journal:  Dis Esophagus       Date:  2016-10       Impact factor: 3.429

4.  Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors:  T W Rice; H Ishwaran; W L Hofstetter; D P Kelsen; C Apperson-Hansen; E H Blackstone
Journal:  Dis Esophagus       Date:  2016-11       Impact factor: 3.429

5.  Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors:  Thomas W Rice; Hemant Ishwaran; David P Kelsen; Wayne L Hofstetter; Carolyn Apperson-Hansen; Eugene H Blackstone
Journal:  Dis Esophagus       Date:  2016-11       Impact factor: 3.429

6.  Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors:  Thomas W Rice; Hemant Ishwaran; Eugene H Blackstone; Wayne L Hofstetter; David P Kelsen; Carolyn Apperson-Hansen
Journal:  Dis Esophagus       Date:  2016-11       Impact factor: 3.429

Review 7.  Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?

Authors:  Yoku Hayakawa; Nilay Sethi; Antonia R Sepulveda; Adam J Bass; Timothy C Wang
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716
  7 in total
  152 in total

1.  Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer.

Authors:  Claire L Donohoe; Alexander W Phillips
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study.

Authors:  George Papaxoinis; Konstantinos Kamposioras; Jamie M J Weaver; Zoe Kordatou; Sofia Stamatopoulou; Theodora Germetaki; Magdy Nasralla; Vikki Owen-Holt; Alan Anthoney; Wasat Mansoor
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

4.  Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

Authors:  Thomas W Rice; Min Lu; Hemant Ishwaran; Eugene H Blackstone
Journal:  J Thorac Oncol       Date:  2019-08-20       Impact factor: 15.609

5.  Endoscopic Submucosal Dissection for Esophageal Adenocarcinoma: A North American Perspective.

Authors:  Philippe Bouchard; Juan-Carlos Molina; Jonathan Cools-Lartigue; Jonathan Spicer; Carmen L Mueller; Lorenzo E Ferri
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

Review 6.  Strategies of nodal staging of the TNM system for esophageal cancer.

Authors:  Wen-Ping Wang; Song-Lin He; Yu-Shang Yang; Long-Qi Chen
Journal:  Ann Transl Med       Date:  2018-02

7.  Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification.

Authors:  Haihong Wang; Yaobing Chen; Guoliang Pi; Ying Zhu; Shengli Yang; Hong Mei; Zhenyu Lin; Tao Zhang
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

Review 8.  Endoscopic Treatment of Early-Stage Esophageal Cancer.

Authors:  Mariam Naveed; Nisa Kubiliun
Journal:  Curr Oncol Rep       Date:  2018-07-30       Impact factor: 5.075

9.  Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature.

Authors:  Lei Liu; Yuanyuan Liu; Longbo Gong; Miao Zhang; Wenbin Wu
Journal:  Cancer Biol Ther       Date:  2020-10-23       Impact factor: 4.742

10.  Incidence and Predictors of Unsuspected Recurrent Laryngeal Nerve Lymph Node Metastases After Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma.

Authors:  Zhi-Gang Li; Xiao-Bin Zhang; Yu-Wen Wen; Yun-Hen Liu; Yin-Kai Chao
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.